These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 10328590)
41. A novel approach to glioma gene therapy: down-regulation of the vascular endothelial growth factor in glioma cells using ribozymes. Ke LD; Fueyo J; Chen X; Steck PA; Shi YX; Im SA; Yung WK Int J Oncol; 1998 Jun; 12(6):1391-6. PubMed ID: 9592205 [TBL] [Abstract][Full Text] [Related]
42. Angiogenesis, protein and gene delivery. Azrin M Br Med Bull; 2001; 59():211-25. PubMed ID: 11756212 [TBL] [Abstract][Full Text] [Related]
43. Antiangiogenic gene therapy in a rat glioma model using a dominant-negative vascular endothelial growth factor receptor 2. Machein MR; Risau W; Plate KH Hum Gene Ther; 1999 May; 10(7):1117-28. PubMed ID: 10340544 [TBL] [Abstract][Full Text] [Related]
44. Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma. Shiose S; Sakamoto T; Yoshikawa H; Hata Y; Kawano Y; Ishibashi T; Inomata H; Takayama K; Ueno H Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2395-403. PubMed ID: 10937546 [TBL] [Abstract][Full Text] [Related]
45. Gene therapy for pancreatic cancer using an adenovirus vector encoding soluble flt-1 vascular endothelial growth factor receptor. Hoshida T; Sunamura M; Duda DG; Egawa S; Miyazaki S; Shineha R; Hamada H; Ohtani H; Satomi S; Matsuno S Pancreas; 2002 Aug; 25(2):111-21. PubMed ID: 12142732 [TBL] [Abstract][Full Text] [Related]
46. Targeting in gene therapy for gliomas. Fueyo J; Gomez-Manzano C; Yung WK; Kyritsis AP Arch Neurol; 1999 Apr; 56(4):445-8. PubMed ID: 10199333 [TBL] [Abstract][Full Text] [Related]
48. The anti-angiogenic role of soluble-form VEGF receptor in malignant gliomas. Takano S; Ishikawa E; Matsuda M; Sakamoto N; Akutsu H; Yamamoto T; Matsumura A Int J Oncol; 2017 Feb; 50(2):515-524. PubMed ID: 28000842 [TBL] [Abstract][Full Text] [Related]
49. Adenoviral-mediated gene transfer induces sustained pericardial VEGF expression in dogs: effect on myocardial angiogenesis. Lazarous DF; Shou M; Stiber JA; Hodge E; Thirumurti V; Gonçalves L; Unger EF Cardiovasc Res; 1999 Nov; 44(2):294-302. PubMed ID: 10690306 [TBL] [Abstract][Full Text] [Related]
50. Vascular endothelial growth/permeability factor expression in human glioma specimens: correlation with vasogenic brain edema and tumor-associated cysts. Strugar JG; Criscuolo GR; Rothbart D; Harrington WN J Neurosurg; 1995 Oct; 83(4):682-9. PubMed ID: 7674019 [TBL] [Abstract][Full Text] [Related]
51. Stereotactic delivery of a recombinant adenovirus into a C6 glioma cell line in a rat brain tumor model. Badie B; Hunt K; Economou JS; Black KL Neurosurgery; 1994 Nov; 35(5):910-5; discussion 915-6. PubMed ID: 7838341 [TBL] [Abstract][Full Text] [Related]
52. Efficient expression of the vascular endothelial growth factor gene in vitro and in vivo, using an adeno-associated virus vector. Byun J; Heard JM; Huh JE; Park SJ; Jung EA; Jeong JO; Gwon HC; Kim DK J Mol Cell Cardiol; 2001 Feb; 33(2):295-305. PubMed ID: 11162134 [TBL] [Abstract][Full Text] [Related]
54. Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Bouvet M; Ellis LM; Nishizaki M; Fujiwara T; Liu W; Bucana CD; Fang B; Lee JJ; Roth JA Cancer Res; 1998 Jun; 58(11):2288-92. PubMed ID: 9622060 [TBL] [Abstract][Full Text] [Related]
55. In situ use of suicide genes for therapy of brain tumours. Wildner O Ann Med; 1999 Dec; 31(6):421-9. PubMed ID: 10680856 [TBL] [Abstract][Full Text] [Related]
56. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development. Hong YK; Chung DS; Joe YA; Yang YJ; Kim KM; Park YS; Yung WK; Kang JK Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823 [TBL] [Abstract][Full Text] [Related]
57. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127 [TBL] [Abstract][Full Text] [Related]
58. Angiogenic gene therapy for heart disease: a review of animal studies and clinical trials. Hammond HK; McKirnan MD Cardiovasc Res; 2001 Feb; 49(3):561-7. PubMed ID: 11166269 [TBL] [Abstract][Full Text] [Related]
59. Immunotherapy with bovine aortic endothelial cells in subcutaneous and intracerebral glioma models in rats: effects on survival time, tumor growth, and tumor neovascularization. Corsini E; Gelati M; Calatozzolo C; Alessandri G; Frigerio S; De Francesco M; Poiesi C; Parati E; Croci D; Boiardi A; Salmaggi A Cancer Immunol Immunother; 2004 Nov; 53(11):955-62. PubMed ID: 15449042 [TBL] [Abstract][Full Text] [Related]
60. Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts. Oku T; Tjuvajev JG; Miyagawa T; Sasajima T; Joshi A; Joshi R; Finn R; Claffey KP; Blasberg RG Cancer Res; 1998 Sep; 58(18):4185-92. PubMed ID: 9751633 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]